Taliscanin and other aristolactams for treating neurological disorders, Parkinson's disease, Alzheimer disease and impotence
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 1, 1988
Grant Date -
N/A
app pub date -
Aug 20, 1987
filing date -
Aug 20, 1987
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A method of treating neurological disorders, in particular Parkinson's disease, is disclosed. The method involves administering an aristolactam, especially Taliscanin, an extract of the root of Aristolochia Taliscana, to an afflicted patient. The dosage is varied in accordance with the patient's response, and generally ranges from 300 to 4000 micrograms per day. Taliscanin has also been shown effective in treating Alzheimer disease and impotence.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully